providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit
www.PAREXEL.com.
This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attrac
'/>"/>
SOURCE PAREXEL International Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference2.
PAREXEL Experts to Address Partnering Best Practices and Innovative Trial Design at Partnerships With CROs Conference3.
PAREXEL Announces Date of Third Quarter Fiscal Year 2009 Earnings Release and Conference Call4.
PAREXEL International to Present at Raymond James 30th Annual Institutional Investors and the Barclays Capital Global Healthcare Conferences5.
PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil6.
PAREXEL Reports Second Quarter Fiscal Year 2009 Financial Results7.
PAREXEL Announces Date of Second Quarter Fiscal Year 2009 Earnings Release and Conference Call8.
PAREXEL Reports Preliminary Second Quarter Results9.
PAREXEL International to Present at NASDAQ OMX 22nd Investor Program10.
PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results11.
PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference